QuiVad

Home / Funds / Qube Research & Technologies Ltd

Qube Research & Technologies Ltd

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on Qube Research & Technologies Ltd by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

1,540 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
December 22, 2021AMG Critical Materials N.V.Netherlands0.61%
December 20, 2021Lakefront Biotherapeutics NVNetherlands1.14%
December 16, 2021Lakefront Biotherapeutics NVNetherlands0.88%
December 14, 2021Lakefront Biotherapeutics NVNetherlands0.93%
December 14, 2021AMG Critical Materials N.V.Netherlands0.52%
December 7, 2021Lakefront Biotherapeutics NVNetherlands1.07%
December 2, 2021Lakefront Biotherapeutics NVNetherlands1.10%
November 30, 2021Koninklijke Vopak N.V.Netherlands0.32%
November 29, 2021Lakefront Biotherapeutics NVNetherlands1.09%
November 29, 2021Koninklijke Vopak N.V.Netherlands0.59%
November 26, 2021Lakefront Biotherapeutics NVNetherlands1.10%
November 26, 2021Koninklijke Vopak N.V.Netherlands0.60%
November 18, 2021Koninklijke Vopak N.V.Netherlands0.51%
November 17, 2021Lakefront Biotherapeutics NVNetherlands1.01%
November 12, 2021Lakefront Biotherapeutics NVNetherlands0.82%
November 11, 2021Lakefront Biotherapeutics NVNetherlands0.78%
November 4, 2021Lakefront Biotherapeutics NVNetherlands0.61%
November 1, 2021AMG Critical Materials N.V.Netherlands0.36%
October 29, 2021AMG Critical Materials N.V.Netherlands0.52%
October 29, 2021Lakefront Biotherapeutics NVNetherlands0.50%
October 26, 2021Lakefront Biotherapeutics NVNetherlands0.44%
October 21, 2021Lakefront Biotherapeutics NVNetherlands0.50%
October 14, 2021Lakefront Biotherapeutics NVNetherlands0.47%
October 13, 2021Lakefront Biotherapeutics NVNetherlands0.51%
October 8, 2021Lakefront Biotherapeutics NVNetherlands0.67%
October 6, 2021Lakefront Biotherapeutics NVNetherlands0.74%
October 4, 2021Lakefront Biotherapeutics NVNetherlands0.64%
September 29, 2021Lakefront Biotherapeutics NVNetherlands0.54%
July 28, 2021Lakefront Biotherapeutics NVNetherlands0.45%
July 27, 2021Lakefront Biotherapeutics NVNetherlands0.53%
July 26, 2021Lakefront Biotherapeutics NVNetherlands0.44%
July 16, 2021Lakefront Biotherapeutics NVNetherlands0.55%
June 26, 2019Banco BPMItaly0.44%
June 21, 2019Banco BPMItaly0.55%
June 4, 2019Banco BPMItaly0.42%
May 31, 2019Banco BPMItaly0.53%
March 21, 2018Credito Valtellinese SPAItaly0.03%
March 19, 2018Credito Valtellinese SPAItaly0.61%
March 16, 2018Credito Valtellinese SPAItaly0.59%
March 14, 2018Credito Valtellinese SPAItaly0.64%

Download 1,540 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Qube Research & Technologies Ltd, data as at October 26, 2026, https://www.quivad.com/detenteur/qube-research-technologies-ltd?page=31